Obesity and vascular risk
- PMID: 19151845
Obesity and vascular risk
Abstract
Obesity is a common disorder and a known risk factor for vascular thrombotic complications. Development of obesity is associated with extensive modifications in adipose tissue involving adipogenesis, angiogenesis and extracellular matrix proteolysis. Studies using a nutritionally induced obesity model in transgenic mice support a role of the fibrinolytic (plasminogen/plasmin) and matrix metalloproteinase (MMP) systems in these processes. Venous or arterial thrombosis models in obese mice confirm a prothrombotic risk associated with obesity.
Similar articles
-
Role of fibrinolysis in obesity and thrombosis.Thromb Res. 2009;123 Suppl 4:S46-9. doi: 10.1016/S0049-3848(09)70143-4. Thromb Res. 2009. PMID: 19303504 Review.
-
Role of proteolysis in development of murine adipose tissue.Thromb Haemost. 2008 Feb;99(2):290-4. doi: 10.1160/TH07-10-0589. Thromb Haemost. 2008. PMID: 18278177 Review.
-
Murine models of obesity and hormonal therapy.Thromb Res. 2011 Feb;127 Suppl 3:S17-20. doi: 10.1016/S0049-3848(11)70006-8. Thromb Res. 2011. PMID: 21262432 Review.
-
Functional role of the fibrinolytic system in development of adipose tissue.Verh K Acad Geneeskd Belg. 2009;71(3):101-13. Verh K Acad Geneeskd Belg. 2009. PMID: 20088250
-
Role of the fibrinolytic and matrix metalloproteinase systems in development of adipose tissue.Arch Physiol Biochem. 2006 Oct-Dec;112(4-5):254-9. doi: 10.1080/13813450601093567. Arch Physiol Biochem. 2006. PMID: 17178599 Review.
Cited by
-
Idiopathic and secondary osteonecrosis of the femoral head show different thrombophilic changes and normal or higher levels of platelet growth factors.Acta Orthop. 2011 Feb;82(1):42-9. doi: 10.3109/17453674.2011.555368. Epub 2011 Feb 1. Acta Orthop. 2011. PMID: 21281264 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical